Ridaura 3 mg – DIN 01916823
Ridaura is Auranofin 3 mg (capsule), sold in Canada. It is used for rheumatoid arthritis, pemphigus and psoriatic arthritis. It is supplied by Xediton Pharmaceuticals Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Auranofin 3 mg
- Brand
- Ridaura
- Strength
- 3 mg
- Used for
- Rheumatoid arthritis, pemphigus and psoriatic arthritis
- Form
- Capsule
- Manufacturer
- Xediton Pharmaceuticals Inc
- Sold in
- Canada
- DIN
- 01916823
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Auranofin used for?
Auranofin is used for rheumatoid arthritis, pemphigus and psoriatic arthritis.
Official uses from the US prescribing label
RIDAURA (auranofin) is indicated in the management of adults with active classical or definite rheumatoid arthritis (ARA criteria) who have had an insufficient therapeutic response to, or are intolerant of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs. RIDAURA should be added to a comprehensive baseline program, including non-drug therapies.
Unlike anti-inflammatory drugs, RIDAURA does not produce an immediate response. Therapeutic effects may be seen after three to four months of treatment, although improvement has not been seen in some patients before six months.
When cartilage and bone damage has already occurred, gold cannot reverse structural damage to joints caused by previous disease. The greatest potential benefit occurs in patients with active synovitis, particularly in its early stage.
In controlled clinical trials comparing RIDAURA with injectable gold, RIDAURA was associated with fewer dropouts due to adverse reactions, while injectable gold was associated with fewer dropouts for inadequate or poor therapeutic effect. Physicians should consider these findings when deciding on the use of RIDAURA in patients who are candidates for chrysotherapy.
From the FDA-approved label on DailyMed (published Nov 17, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 01916823.
- It names Ridaura, Auranofin 3 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Ridaura by Xediton Pharmaceuticals Inc.
In Canada: prescription only.
Ingredients
Active: Auranofin